FAQ

sulfoquinovosylacylglycerol

Known as: SQAG compound, SQAG9, Sulfo-quinovosyl-acyl-glycerol 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2006
01220042006

Related topics

Related topics

1 relation

Broader (1)

Glycolipids

Related mentions per year

Related mentions per year

1951-2018
1960198020002020
sulfoquinovosylacylglycerol
Glycolipids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Effects of a new immunosuppressive agent, beta-SQAG9, in swine kidney transplantation.
We previously reported that 1,2-di-O-acyl-3-O-(-D-sulfoquinovosyl)-glyceride with two stearic acids (beta-SQAG9) bound to L… (More)
Is this relevant?
2006
2006
An Emulsion of Sulfoquinovosylacylglycerol with Long-Chain Alkanes Increases Its Permeability to Tumor Cells
The α-anomer form of sulfoquinovosyl-monoacylglycerol with a saturated C18 fatty acid (α-SQMG-C18:0) is a natural sulfolipid that… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2005
2005
Mechanism of the immunosuppressive effect in vivo of novel immunosuppressive drug beta-SQAG9, which inhibits the response of the CD62L+ T-cell subset.
INTRODUCTION We synthesized sulfo-glycolipid, beta-SQAG9 (designate square beta-SQAG9 liposome, because it efficiently forms a… (More)
Is this relevant?
2004
2004
Synthetic sulfonolipids deduced from sulfonoquinovosyl diacylglycerols of sea urchin reduces hepatic ischemia-reperfusion injury in rats.
BACKGROUND In hepatic surgery and liver transplantation, ischemia-reperfusion (I/R) is an unavoidable process, and protection… (More)
Is this relevant?
2004
2004
Synthesis of an immunosuppressant SQAG9 and determination of the binding peptide by T7 phage display.
SQAG9, a new class of immunosuppressive sulfoquinovosylacylglycerol, and its biotinylated derivatives have been synthesized. A T7… (More)
Is this relevant?